Aspirin dose comparison after heart stent placement
Treatments studied
Part of Heart & circulation clinical trials.
This study compares two different daily doses of aspirin (50 mg vs 100 mg) when taken with a standard blood thinner (P2Y12 inhibitor) after getting a heart stent. It aims to see if a lower aspirin dose works just as well with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have been diagnosed with acute coronary syndrome or chronic coronary syndrome.
- You have had a stent placed in your heart artery (percutaneous coronary intervention).
- You are planning to take two blood-thinning medicines (aspirin and a P2Y12 inhibitor) for at least a year after your stent.
- You do not have a high risk of bleeding, severe liver or kidney disease, or had a recent stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This study compares two ways of choosing blood thinners after a heart stent procedure. It aims to see if using an imaging-guided strategy leads to better outcomes than usual care.
This study looks at whether taking just one blood-thinning medicine (instead of two) after a stent procedure helps prevent future heart problems while lowering the risk of bleeding. It's for people who recently had a heart attack or unstable chest pain and had a stent placed.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This trial tests whether a lower dose of aspirin combined with another blood thinner (prasugrel) after bypass surgery is as safe and effective as a higher dose. It is for people with stable heart disease who are scheduled for bypass surgery and have not had a recent heart attack.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.